Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb Market Cap : 137.51B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 136.90B |
| August 20, 2026 | 133.76B |
| August 19, 2026 | 138.13B |
| August 18, 2026 | 134.94B |
| August 17, 2026 | 132.04B |
| August 14, 2026 | 130.40B |
| August 13, 2026 | 132.08B |
| August 12, 2026 | 130.14B |
| August 11, 2026 | 129.96B |
| August 10, 2026 | 132.47B |
| August 07, 2026 | 132.22B |
| August 06, 2026 | 131.06B |
| August 05, 2026 | 130.00B |
| August 04, 2026 | 134.61B |
| August 03, 2026 | 133.76B |
| July 31, 2026 | 133.43B |
| July 30, 2026 | 132.51B |
| July 29, 2026 | 128.91B |
| July 28, 2026 | 129.93B |
| July 27, 2026 | 127.81B |
| July 24, 2026 | 126.79B |
| July 23, 2026 | 125.60B |
| July 22, 2026 | 124.07B |
| July 21, 2026 | 124.42B |
| July 20, 2026 | 122.85B |
| Date | Value |
|---|---|
| July 17, 2026 | 124.03B |
| July 16, 2026 | 123.56B |
| July 15, 2026 | 119.91B |
| July 14, 2026 | 116.29B |
| July 13, 2026 | 121.17B |
| July 10, 2026 | 117.58B |
| July 09, 2026 | 118.31B |
| July 08, 2026 | 117.50B |
| July 07, 2026 | 118.37B |
| July 06, 2026 | 115.78B |
| July 02, 2026 | 118.70B |
| July 01, 2026 | 115.25B |
| June 30, 2026 | 117.66B |
| June 29, 2026 | 119.58B |
| June 26, 2026 | 117.46B |
| June 25, 2026 | 113.11B |
| June 24, 2026 | 112.31B |
| June 23, 2026 | 113.39B |
| June 22, 2026 | 111.70B |
| June 18, 2026 | 110.27B |
| June 17, 2026 | 112.88B |
| June 16, 2026 | 114.19B |
| June 15, 2026 | 114.84B |
| June 12, 2026 | 116.66B |
| June 11, 2026 | 116.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 657.57B |
| Eli Lilly & Co. | 1.175T |
| Merck & Co., Inc. | 372.07B |
| Pfizer Inc. | 159.46B |
| AstraZeneca PLC | 517.36B |
Market Cap Related Metrics
| PE Ratio | 14.83 |
| PS Ratio | 2.796 |
| PEG Ratio | 0.1783 |
| Price to Book Value | 6.161 |
| Price to Free Cash Flow | 12.02 |
| Price | 67.31 |
| Earnings Yield | 6.74% |
| PEGY Ratio | 0.1707 |
| Operating PE Ratio | 8.643 |
| Normalized PE Ratio | 10.96 |